Repligen Corporation (NASDAQ:RGEN) Q1 2026 Earnings Call Transcript
Jacob Johnson: And we'll provide financial guidance for the full year 2026.
Repligen Corp (RGEN)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Roubaix Capital Christopher Hillary | 54,555 | $6,427,670 | 3% | |
| 2. | 2,474,000 | $2,415,554 | +210% | 0.02% | |
| 3. | Bayforest Capital Theodoros Tsagaris | 39 | $4,595 | -80% | 0.01% |
| 4. | Leucadia National Ian Cumming And Joseph Steinberg | 0 | $0 | 0% | |
| 5. | Sivik Global Healthcare Krishen Sud | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $112.13 | 1,800 | $201,830.40 | 1,800 | 2025-08-08 | Filing | |
| $150.69 | 250 | $37,672.50 | 1,043 | 2025-03-17 | Filing | |
| $125.46 | 700 | $87,822.00 | 4,613 | 2024-06-14 | Filing | |
| $124.54 | 915 | $113,954.10 | 3,913 | 2024-06-14 | Filing | |
| $125.45 | 1,200 | $150,540.00 | 4,668 | 2024-06-14 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $140.00 | 3,832 | $536,480.00 | 54,246 | 2026-04-21 | Filing | |
| $161.00 | 275 | $44,275.00 | 91,821 | 2025-12-17 | Filing | |
| $170.00 | 7,041 | $1,196,970.00 | 35,898 | 2025-11-25 | Filing | |
| $151.21 | 2,191 | $331,301.11 | 21,520 | 2025-11-18 | Filing | |
| $157.11 | 1,956 | $307,307.16 | 80,743 | 2025-11-13 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 2,396,511 | $282,356,926 | 0.01% | |
| 2. | 2,305,094 | $271,586,175 | 0.01% | |
| 3. | 1,531,402 | $180,429,810 | 0.03% | |
| 4. | 1,243,531 | $146,512,822 | 0.97% | |
| 5. | 1,097,783 | $129,340,793 | 2.58% |
News See All
Tempered Forward Expectations Hurt Repligen Corp. (RGEN) in Q1
Conestoga Capital Advisors, an asset management company, released its first-quarter 2026 investor letter. A copy of the letter can be downloaded here.
Here’s What Positioned Repligen Corporation (RGEN) for a Durable Long-Term Growth
Fred Alger Management, an investment management company, released its “Alger Mid Cap Fund” first-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Repligen Corporation (NASDAQ:RGEN) Q4 2025 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. My name is [ Jereko ] and I'll be your conference operator today.
Repligen Corp. (RGEN) Rose as Industrial Destocking Decreased and Order Patterns Stabilized
Conestoga Capital Advisors, an asset management company, released its fourth-quarter 2025 investor letter. As many believe, US equities experienced solid returns in 2025, with double-digit gains across...
What Makes Repligen Corporation (RGEN) an Investment Choice?
Baron Funds, an investment management company, released its fourth-quarter investor letter for the “Baron Health Care Fund”. A copy of the letter can be downloaded here.
UBS Tags Repligen (RGEN) as Bioprocessing Leader for 2026, Cites 20% Order Growth and Reshoring Tailwinds
Repligen Corporation (NASDAQ:RGEN) is one of the best mid-cap growth stocks to buy right now.
14 Best Mid-Cap Growth Stocks to Buy Right Now
On January 8, Nancy Prial, Co-CEO & Senior Portfolio Manager at Essex Investment Management, appeared on CNBC and suggested she sees significant upside in 2026 for undiscovered small- and midcap firms...
Here’s Why Sands Capital Global Growth Fund Decided to Sell Repligen Corporation (RGEN)
Sands Capital, an investment management company, released its “Sands Capital Global Growth Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Is Repligen (RGEN) The Best Healthcare Stock to Buy Now?
Dan Veru, Palisade Capital Management senior partner and CIO, recently talked about Repligen, a life sciences company involved in the development and production of materials used in the manufacture of...